Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Carcinoma, Basal Cell 15Neoplasms 5Pancreatic Neoplasms 4Stomach Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Medulloblastoma 3Colorectal Neoplasms 3Basal Cell Nevus Syndrome 3Urinary Bladder Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Adenocarcinoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Platinum-Resistant Fallopian Tube Carcinoma 1Pancreatic Diseases 1Odontogenic Cysts 1Neuroectodermal Tumors, Primitive 1Neoplasms, Unknown Primary 1Neoplasms, Basal Cell 1Neoplasms by Site 1

Interventions

Cyclophosphamide 58Dexamethasone 50Rituximab 39Peripheral Blood Stem Cell Transplantation 29Paclitaxel 29Lenalidomide 28fludarabine phosphate 27Gemcitabine 26Etoposide 26Bortezomib 26Cytarabine 25Busulfan 24pembrolizumab 21Radiotherapy 21Bevacizumab 21Carboplatin 20Mycophenolic Acid 19Melphalan 19Cisplatin 19Filgrastim 18pomalidomide 17fludarabine 17Oxaliplatin 17Antilymphocyte Serum 17Cyclosporine 16Tacrolimus 15Methotrexate 15Whole-Body Irradiation 14Methylprednisolone 13Bendamustine Hydrochloride 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Recurrence × HhAntag691 × Clear all
NCT01944943 2017-03-13

VISMOLY

The Lymphoma Academic Research Organisation

Phase 2 Terminated
31 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡